SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028478
Filing Date
2016-11-09
Accepted
2016-11-09 08:01:13
Documents
60
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clcd-10q_20160930.htm 10-Q 1443997
2 EX-31.1 clcd-ex311_9.htm EX-31.1 8059
3 EX-31.2 clcd-ex312_7.htm EX-31.2 8059
4 EX-32.1 clcd-ex321_8.htm EX-32.1 6588
5 EX-32.2 clcd-ex322_6.htm EX-32.2 6588
  Complete submission text file 0001564590-16-028478.txt   6054801

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clcd-20160930.xml EX-101.INS 1434305
7 XBRL TAXONOMY EXTENSION SCHEMA clcd-20160930.xsd EX-101.SCH 43121
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcd-20160930_cal.xml EX-101.CAL 31299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcd-20160930_def.xml EX-101.DEF 152716
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcd-20160930_lab.xml EX-101.LAB 345530
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcd-20160930_pre.xml EX-101.PRE 265980
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Filer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37358 | Film No.: 161982839
SIC: 2834 Pharmaceutical Preparations